RAD December 2021 Conference Abstracts and Posters
All accepted abstracts will be published in the British Journal of Dermatology.671 - Real-world Effectiveness of Dupilumab in Moderate Atopic Dermatitis: Improvement in Investigator Global Assessment Scores in an Electronic Medical Records Dataset
Lawrence F. Eichenfield, April Armstrong, Emma Guttman-Yassky, Peter A. Lio, Chi-Chang Chen, Dionne M. Hines, Catherine B. McGuiness, Gaëlle Bégo-Le-Bagousse, Dimittri Delevry
672 - A Study of Past, Present, and Future Shared Decision Making Among Eczema Patients and Caregivers
Isabelle Thibau, MPH, Emile Latour, MS, Allison Loiselle, PhD, Erin Foster, MD, PhD, Wendy Smith Begolka, MBS
673 - Patient vs Provider Reported Outcomes in a Multidisciplinary Atopic Dermatitis Clinic
Margaret M Appiah BS; Lauren Loop BS; Norma Villapando PA-C; Elana Kleinman BS; Jennifer Laborada BS; Bob Geng MD; Lawrence Eichenfield MD
674 - New Findings Demonstrate that Application of B244 Reduces Inflammatory and Pruritic Cytokines
Daniel Brownell, Hyun Kim, Connie Li, Damien Maura, Nazik Elmekki, C. Alex Goddard
675 - Effects of Ruxolitinib Cream on Pruritus and Sleep in Atopic Dermatitis: 52-Week Pooled Results From Two Phase 3 Studies
Eric L. Simpson, MD, MCR, Mark Boguniewicz, MD, Diamant Thaçi, MD, Laurent Misery, MD, April W. Armstrong, MD, MPH, Jonathan I. Silverberg, MD, PhD, MPH, May E. Venturanza, MD, Howard Kallender, PhD, Jessy Gao, MA, Jacek C. Szepietowski, MD, PhD, FRCP (Edin)
676 - Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Pooled Results From Two Phase 3 Studies
Kim Papp, MD, PhD, Jacek C. Szepietowski, MD, PhD, FRCP (Edin), Leon Kircik, MD, Darryl Toth, MD, Lawrence F. Eichenfield, MD, Seth B. Forman, MD, Michael E. Kuligowski, MD, PhD, MBA, May E. Venturanza, MD, Haobo Ren, PhD, Eric L. Simpson, MD, MCR
677 - Elevated circulating blood eosinophils and inflammatory laboratory markers as predictors of adverse systemic outcomes in patients with atopic dermatitis: a multicenter cohort study
Junwen Deng, BA, Varsha Parthasarathy, BS, Zachary Bordeaux, BS, Mindy Szeto, MS, Martin Alphonse, PhD, Shawn G. Kwatra, MD
678 - Characterization of Hematologic and Transaminase Laboratory Findings Associated With Upadacitinib Use in Moderate-to-Severe Atopic Dermatitis: Results of Two Phase 3 Trials (Measure Up 1 and 2)
Jonathan I. Silverberg, Melinda J. Gooderham, Marjolein S. de Bruin-Weller, Kim A. Papp, Valeria Aoki, Amy S. Paller, Sarah Ofori, Allan R. Tenorio, Yingyi Liu, Jianzhong Liu, Raj Chovatiya
680 - Identifying Patient Subgroups With Comparable Benefit From Continuous Versus Reduced Abrocitinib Maintenance Doses in JADE REGIMEN
Jonathan I. Silverberg, Andrew Blauvelt, Eric L. Simpson, Jacob P. Thyssen, Pinaki Biswas, Claire Feeney, Ricardo Rojo, Herwig Koppensteiner, Erman Guler, Urs Kerkmann, Stephan Weidinger
681 - Onset and Depth of Response with Abrocitinib Versus Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: Analysis of the Phase 3b JADE DARE Clinical Trial
Kristian Reich, Fernando Valenzuela, H. Chih-ho Hong, Kilian Eyerich, Zakiya Pressley Rice, Ankur Bhambri, Erman Guler, Fan Zhang, Ricardo Rojo, Gary Chan, Claire Clibborn